Crossmark

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Crossref DOI link: https://doi.org/10.1186/s12885-017-3150-7

Published Online: 2017-02-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Luo, Yanji

Chen, Jie

Huang, Kun

Lin, Yuan

Chen, Minhu

Xu, Ling

Li, Zi-Ping

Feng, Shi-Ting
Funding

Funding for this research was provided by:

National Natural Science Foundation ofChina (CN) (81571750)

Natural Science Foundation of Guangdong Province (2014A030310484)

Natural Science Foundation of Guangdong Province (2014A030310484)

Document is current

Any future updates will be listed below